Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib Biomarker Trial in Advanced Pancreatic Cancer
NCT00674973Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of erlotinib in pancreatic cancer (PC), sponsored by Roche. Started Jun 2008; status: completed.
02
Drugs
erlotinib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00674973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674973.